Hip Scope Fascia-iliaca (FI) Block Study

• Status: Completed
• Trial end date: 2017-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Hawkins Foundation
• Treatments: Clonidine; Epinephrine; Epinephryl borate; Racepinephrine

Criteria

Inclusion Criteria:

• Scheduled for outpatient hip arthroscopy

• American Society of Anesthesiologists (ASA) 1-3

Exclusion Criteria:

• Prior surgery on ipsilateral hip

• ASA 4-6

• Chronic narcotic usage over 6 months or more than the equivalent of 20mg of morphine per day

• Current or prior placement of a spinal cord stimulator or intrathecal pump for pain control purposes

• Allergy to amide local anesthetics

• Contraindication to regional anesthesia

• BMI > 40

• Females who are pregnant or plan to get pregnant during the course of the study